AFRI-EQA participant Enrolment form
Background
Launched by ASLM in 2025, Afri-EQA is a continental initiative expanding access to high-quality, affordable External Quality Assessment (EQA) services for laboratories across Africa. By addressing key barriers including high participation and shipping costs, limited EQA availability, and gaps in accredited providers and trained personnel Afri-EQA strengthens the quality of laboratory testing across the One Health spectrum. Supported by ASLM’s technical expertise, institutional capacity, and continental partnerships, the program is helping laboratories improve testing quality and performance.
Thank you for your interest in participating in the Afri-EQA proficiency testing program. To complete your enrollment, please review the information below and fill in the required sections.
Section A – Facility Identifier details
Section B – 2026 Shipping Schedule
Section C – Additional support for enrolled laboratories
Section D - Selection of available PT Schemes & pricelist in 2026
Section E – Acknowledgement form
Completed form to be sent to the Afri-EQA email at
afri-eqa@aslm.org
Due date: Submit the signed acknowledgement form by Monday 20 July 2026
SECTION A: FACILITY IDENTIFIER DETAILS
Institution / Facility / unit name
(Required)
Province
(Required)
Country
(Required)
Country
Botswana
Cabo Verde
Cameroon
Chad
Ethiopia
Gabon
Malawi
Mozambique
Nigeria
Seychelles
Sierra Leone
Togo
Uganda
Zambia
Zimbabwe
Physical address
Name of primary contact person
(Required)
Phone number of primary contact person
(Required)
Email address of primary contact person
(Required)
Name of secondary contact person (e.g. laboratory supervisor)
Phone secondary of primary contact person (e.g. laboratory supervisor)
Email address of secondary contact person
B: SHIPPING SCHEDULE
Chemistry
Haematology
Parasitology & Serology
SECTION C: ADDITIONAL SUPPORT FOR ENROLED LABORATORIES
In addition to providing PT panels Afri-EQA will provide comprehensive performance reports with detailed analysis of results, interpretation of findings, and benchmarking against peer laboratories. Where unsatisfactory performance is identified, laboratories will receive assistance with root cause analysis, corrective and preventive actions and opportunities for follow-up consultation. Additional support will include a webinar conducted at the end of each cycle to understand the expected performance and areas of improvement. Afri-EQA will also maintain responsive technical assistance for participant inquiries, provide timely notifications regarding PT schedules and reporting deadlines, and issue certificates of participation and performance where applicable.
SECTION D: SELECTION OF AVAILABLE PT SCHEME IN 2026
Select your preferred tests using the pricelist below, all prices are in
United States Dollars
Clinical Chemistry
CLINICAL CHEMISTRY
BHCG – Qualitative Urine
C-Reactive Protein
Endocrinology
General Chemistry
HAEMATOLOGY
ESR
Haematology Full Blood Count
Automated Differential Count
Morphology and Manual Diff Count
HAEMATOLOGY
PARASITOLOGY
PARASITOLOGY
Blood Parasites
Stool/Faecal Parasites
SEROLOGY
HBsAg Serology
HIV Serology
Syphilis: Non Treponemal
Hepatitis A IgM Serology
SEROLOGY
MICROBIOLOGY
MICROBIOLOGY
Bacteriology
Molecular HIV Viral Load
Shipping Cost Per Cycle
Price:
Shipping Cost Per Cycle
Price:
Shipping Cost Per Cycle
Price:
Shipping Cost Per Cycle
Price:
Total Estimated Cost
SECTION E ACKNOWLEDGEMENT & AGREEMENT FORM
Name of person completing the form
(Required)
Designation at laboratory
(Required)
Consent
(Required)
I agree
By clicking "I agree" in this form, the participating laboratory confirms its intention to voluntarily enroll in the Afri-EQA PT Program and agrees to comply with all applicable program requirements. The laboratory acknowledges its responsibility to participate in scheduled PT rounds, ensure that PT samples are handled and tested in the same manner as routine patient specimens, submit results within the specified timelines, maintain the confidentiality of PT materials and results, and cooperate in any required follow-up activities, including investigation and corrective actions where performance is unsatisfactory. The laboratory further confirms that the information provided during enrolment is accurate and complete and understands that participation in the PT program is intended to support continuous quality improvement, monitor testing performance, and strengthen confidence in the accuracy of laboratory results.
